To clarify the involvement of central serotonergic systems in the behavioral effects of hallucinogens in rats, studies of hallucinogen-induced decreases in startle habituation and increases in behavioral measures of neophobia will be extended to include 3,4-methylenedioxy amphetamine (MDA), 3,4-methylenedioxy-N- methylamphetamine (MDMA, """"""""Ecstasy""""""""), N-ethyl-3,4-methylenedioxy- amphetamine (MDEA, Eve), and their stereoisomers. The behavioral effects of the hallucinogens and related drugs will be thoroughly characterized using measures of acoustic and tactile startle responses and a computerized Behavioral Pattern Monitor that provides detailed information regarding the amount and qualitative patterning of spontaneous activity and investigatory responses to specifiable environmental stimuli. The ability of serotonin releasing agents, such as p-chloroamphetamine (PCA) and fenfluramine, to mimic the effects of the hallucinogens and the ability of serotonin-2 antagonists to block them will be determined. The effects of selective neurotoxic lesions of serotonin in localized protection sites in brain will be similarly characterized. Lesion effectiveness and specificity will be assessed with histofluorescence microscopy and regional monoamine assays using liquid chromatography with electrochemical detection. The hypothesis that specific serotonergic terminal regions are responsible for the acute effects of MDA, MDMA, MDEA, and PCA on startle habituation and the potentiation of neophobia will be tested by examining the effects of these drugs in lesioned animals. Experiments will also test the possibility that neurotoxic lesions or acute administrations of the hallucinogenic amphetamine derivatives lead to long-lasting changes in the behavioral responsiveness of animals to serotonergic agonists. This work should further our understanding of the basic neural mechanisms mediating the behavioral effects of these drugs of abuse. facilitate the development of antagonists for their effects, and begin to clarify the long-term functional consequences of their use.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002925-09
Application #
3207639
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1981-09-30
Project End
1993-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
9
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Halberstadt, Adam L; Geyer, Mark A (2018) Effect of Hallucinogens on Unconditioned Behavior. Curr Top Behav Neurosci 36:159-199
Brandt, Simon D; Kavanagh, Pierce V; Westphal, Folker et al. (2017) Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ). Drug Test Anal 9:38-50
Brandt, Simon D; Kavanagh, Pierce V; Dowling, Geraldine et al. (2017) Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives. Drug Test Anal 9:115-126
Halberstadt, Adam L (2017) Pharmacology and Toxicology of N-Benzylphenethylamine (""NBOMe"") Hallucinogens. Curr Top Behav Neurosci 32:283-311
Halberstadt, Adam L; Hyun, James; Ruderman, Michael A et al. (2016) Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice. Pharmacol Biochem Behav 148:69-75
Halberstadt, Adam L (2016) Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine. Pharmacol Biochem Behav 143:1-10
Wallach, Jason; Kang, Heather; Colestock, Tristan et al. (2016) Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues. PLoS One 11:e0157021
Brandt, Simon D; Kavanagh, Pierce V; Westphal, Folker et al. (2016) Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Drug Test Anal 8:891-902
Halberstadt, Adam L; Slepak, Natalia; Hyun, James et al. (2016) The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents. Psychopharmacology (Berl) 233:1215-25
Halberstadt, Adam L; Sindhunata, Ivan S; Scheffers, Kees et al. (2016) Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice. Neuropharmacology 107:364-375

Showing the most recent 10 out of 151 publications